Scientists develop COVID-19 antibody measurement technology to rapidly assess virus blocking efficacy

Researchers have developed the hybrid alphavirus-SARS-CoV-2 pseudovirus system that can robustly express reporter genes in cells within hours to rapidly measure neutralizing antibodies. Ha-CoV-2 pseudovirus was utilized against the COVID-19 virus and its variants including Alpha, Delta, and Omicron, as well as the currently emerging omicron BA.2 variant.

Source: sciencedaily.com

Related posts

Otters, especially females, use tools to survive a changing world

Researchers wrestle with accuracy of AI technology used to create new drug candidates

How did sabre-toothed tigers acquire their long upper canine teeth?